These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36148698)

  • 1. Circulating cardiovascular biomarkers during and after preeclampsia: Crosstalk with placental function?
    Jacobsen DP; Røysland R; Strand H; Moe K; Sugulle M; Omland T; Staff AC
    Pregnancy Hypertens; 2022 Dec; 30():103-109. PubMed ID: 36148698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia.
    Anto EO; Coall DA; Asiamah EA; Afriyie OO; Addai-Mensah O; Wiafe YA; Owiredu W; Obirikorang C; Annani-Akollor ME; Titiloye NA; Adua E; Acheampong E; Adu EA; Opoku S; Anto AO; Tawiah A; Wang Y; Wang W
    PLoS One; 2022; 17(3):e0265717. PubMed ID: 35312727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
    Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
    Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular biomarkers in pregnancy with diabetes and associations to glucose control.
    Jacobsen DP; Røysland R; Strand H; Moe K; Sugulle M; Omland T; Staff AC
    Acta Diabetol; 2022 Sep; 59(9):1229-1236. PubMed ID: 35796791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China.
    Li B; Yang H
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):186. PubMed ID: 35260082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of maternal serum progesterone-induced blocking factor levels in pregnancies complicated with early- and late-onset preeclampsia.
    Sahin E; Madendag Y; Eraslan Sahin M; Col Madendag I; Kirlangic MM; Muhtaroglu S
    J Obstet Gynaecol; 2022 Aug; 42(6):1991-1995. PubMed ID: 35648816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal characteristics, mean arterial pressure and serum markers in early prediction of preeclampsia.
    Kuc S; Koster MP; Franx A; Schielen PC; Visser GH
    PLoS One; 2013; 8(5):e63546. PubMed ID: 23717445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental hypoplasia and maternal organic vascular disorder in pregnant women with gestational hypertension and preeclampsia.
    Owaki Y; Watanabe K; Iwasaki A; Saitou T; Matsushita H; Wakatsuki A
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):353-359. PubMed ID: 30983440
    [No Abstract]   [Full Text] [Related]  

  • 11. NT-proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery.
    Lafuente-Ganuza P; Carretero F; Lequerica-Fernández P; Fernandez-Bernardo A; Escudero AI; de la Hera-Galarza JM; Garcia-Iglesias D; Alvarez-Velasco R; Alvarez FV
    Clin Chem Lab Med; 2021 May; 59(6):1077-1085. PubMed ID: 33581001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia.
    Álvarez-Fernández I; Prieto B; Rodríguez V; Ruano Y; Escudero AI; Álvarez FV
    Clin Chim Acta; 2016 Dec; 463():150-157. PubMed ID: 27983995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and postpartum levels of circulating maternal sHLA-G in preeclampsia.
    Jacobsen DP; Lekva T; Moe K; Fjeldstad HES; Johnsen GM; Sugulle M; Staff AC
    J Reprod Immunol; 2021 Feb; 143():103249. PubMed ID: 33254097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus.
    Sugulle M; Dechend R; Herse F; Weedon-Fekjaer MS; Johnsen GM; Brosnihan KB; Anton L; Luft FC; Wollert KC; Kempf T; Staff AC
    Hypertension; 2009 Jul; 54(1):106-12. PubMed ID: 19470878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6.
    Negi R; Haritha V; Aziz N; Siddiqui AH
    Mol Cell Biochem; 2022 Jun; 477(6):1765-1774. PubMed ID: 35292877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of maternal serum hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia.
    Alici Davutoğlu E; Akkaya Firat A; Ozel A; Yılmaz N; Uzun I; Temel Yuksel I; Madazlı R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(15):1976-1982. PubMed ID: 28574293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental expression of proBNP/NT-proBNP and plasma levels of NT-proBNP in early- and late-onset preeclampsia.
    Junus K; Wikström AK; Larsson A; Olovsson M
    Am J Hypertens; 2014 Sep; 27(9):1225-30. PubMed ID: 24610898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provoking factors for postpartum chronic hypertension in women with preceding gestational hypertension/preeclampsia: A longitudinal cohort study of 22,798 pregnancies.
    Chen KH; Chen LR
    Int J Med Sci; 2020; 17(4):543-548. PubMed ID: 32174785
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.
    Aldika Akbar MI; Herdiyantini M; Aryananda RA; CIninta N; Wardhana MP; Gumilar KE; Wicaksono B; Ernawati ; Sulistyono A; Aditiawarman ; Joewono HT; Nadir Abdullah ; Dekker G; Dachlan EG; Dikman Angsar M
    Hypertens Pregnancy; 2018 Nov; 37(4):175-181. PubMed ID: 30277426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.